Ecco la lista completa delle citazioni degli articoli presenti nelle fonti:
- Ciaccia A. et al. (1994). “Pidotimod Activity against Chronic Bronchitis Exacerbations”. Arzneimittel-Forschung/Drug Research, 44 (II), Nr. 12a, 1516-1520.
- Cogo R. (2014). “Valutazione sperimentale controllata dell’attività di Pidotimod in pazienti affetti da BPCO”. Minerva Pneumologica, Vol. 53 – No. 1, 1-6.
- Esposito S. et al. (2015). “Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia”. Journal of Translational Medicine, 13:288.
- Licari A. et al. (2014). “Pidotimod may prevent recurrent respiratory infections in children”. Minerva Pediatrica, Vol. 66 – No. 1, 1-5.
- Marogna M. & Ciprandi G. (2021). “Pidotimod as add-on therapy in patients with pollen-induced allergic rhinitis and asthma and associated respiratory infections”. Journal of Biological Regulators & Homeostatic Agents, Vol. 35, no. 3, 1053-1058.
- Motta G. et al. (1994). “Immunoactivity of Pidotimod against Recurrent Tonsillitis in Childhood”. Arzneimittel-Forschung/Drug Research, 44 (II), Nr. 12a, 1521-1524.
- Ucciferri C. et al. (2022). “New Therapeutic Options in Mild Moderate COVID-19 Outpatients”. Microorganisms, 10, 2131.